Second Opinions Don't Significantly Delay Breast Cancer Treatment
By Dennis Thompson HealthDay Reporter
TUESDAY, May 6, 2025 (HealthDay news) -- It’s natural to feel a wave of anxiety following a diagnosis of breast cancer.
But women shouldn’t let worries about delaying treatment deter them from seeking a second opinion on their diagnosis and treatment, researchers say.
Patients who got a second opinion following their initial biopsy still proceeded promptly to treatment, researchers reported Friday at the annual meeting of the American Society of Breast Surgeons in Las Vegas.
“Time from biopsy to first treatment fell well within the Commission on Cancer (CoC) guidelines,” researcher Dr. Pooja Varman, a general surgery resident at the Cleveland Clinic, said in a news release.
For the study, researchers tracked 226 patients newly diagnosed with breast cancer between January and July 2024 and treated at the Cleveland Clinic.
Patients who sought a second opinion at the Cleveland Clinic began treatment after an average 41 days, compared with 35 days for those who started treatment at the clinic, results show.
The average time from the first appointment with a cancer surgeon to first treatment was 21 days, with no statistical difference between those who came to the clinic first or came for a second opinion.
The Commission on Cancer (CoC) guidelines call for treatment initiation within 60 days, researchers noted.
Radiologists often recommended additional workup for people arriving for a second opinion, 68% versus about 26%, results show.
However, surgeons tended to recommend additional workup at similar rates between the two groups, 61% versus 64%.
Researchers said people who came for a second opinion required additional imaging and biopsies about 90% of the time, compared with 68% for those who started treatment at the clinic.
“Breast cancer is a life-altering experience,” Varman said. “For patients, exploring all treatment options and finding a physician and clinical team they are comfortable with is crucial.”
She noted that patients seek second opinions for a "wide variety" of reasons.
“Cancer treatment is a physically and emotionally difficult journey and feeling comfortable with the path chosen is extremely important," Varman said. "This study should reassure patients that a second opinion need not impact all-important timeliness of care.”
Findings presented at medical meetings should be considered preliminary unless published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-07 00:00
Read more

- U.S. Sees Most Child Flu Deaths Since 2009
- Middle-Age Exercise Protects Brain Against Alzheimer's
- United States Seeing Uptick in Whooping Cough Cases
- FDA and Novo Nordisk Alert Consumers to Counterfeit Ozempic
- FDA Accepts Filing Application for Oral Semaglutide 25 mg, Which If Approved, Would Be The First Oral GLP-1 Treatment for Obesity
- CBD Could Calm Kids With Autism
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions